Clinical trial
Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis - a Multi-centre, Randomised, Double-masked, Parallel-group, Phase IV Comparison
NCT01357538 is registered in ClinicalTrials.gov with Ursapharm Arzneimittel GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis - a Multi-centre, Randomised, Double-masked, Parallel-group, Phase IV Comparison
- Lead sponsor
- Ursapharm Arzneimittel GmbH
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- August 31, 2009
- Enrollment
- 197 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.